Theodoros Soldatos1, Shivani Ahlawat1, Elizabeth Montgomery1, Majid Chalian1, Michael A Jacobs1, Laura M Fayad1. 1. From the Department of Radiology and Medical Imaging, Victoria Hospital, NHS Fife, Kirkcaldy, United Kingdom (T.S.); Russell H. Morgan Department of Radiology and Radiological Science (S.A., M.C., M.A.J., L.M.F.), Sidney Kimmel Comprehensive Cancer Center (E.M., M.A.J., L.M.F.), and Department of Pathology (E.M.), Johns Hopkins University Hospital, 601 N Wolfe St, Baltimore, MD 21287.
Abstract
PURPOSE: To determine the added value of quantitative diffusion-weighted and dynamic contrast material-enhanced imaging to conventional magnetic resonance (MR) imaging for assessment of the response of soft-tissue sarcomas to neoadjuvant therapy. MATERIALS AND METHODS: MR imaging examinations in 23 patients with soft-tissue sarcomas who had undergone neoadjuvant therapy were reviewed by two readers during three sessions: conventional imaging (T1-weighted, fluid-sensitive, static postcontrast T1-weighted), conventional with diffusion-weighted imaging, and conventional with diffusion-weighted and dynamic contrast-enhanced imaging. For each session, readers recorded imaging features and determined treatment response. Interobserver agreement was assessed and receiver operating characteristic analysis was performed to evaluate the accuracy of each session for determining response by using results of the histologic analysis as the reference standard. Good response was defined as less than or equal to 5% residual viable tumor. RESULTS: Of the 23 sarcomas, four (17.4%) showed good histologic response (three of four with >95% granulation tissue and <5% necrosis, one of four with 95% necrosis and <5% viable tumor) and 19 (82.6%) showed poor response (viable tumor range, 10%-100%). Interobserver agreement was substantial or excellent for imaging features in all sequences (k = 0.789-1.000). Receiver operating characteristic analysis showed an increase in diagnostic performance with the addition of diffusion-weighted and dynamic contrast-enhanced MR imaging for prediction of response compared with that for conventional imaging alone (areas under the curve, 0.500, 0.676, 0.821 [reader 1] and 0.506, 0.704, 0.833 [reader 2], respectively). CONCLUSION: Adding functional sequences to the conventional MR imaging protocol increases the sensitivity of MR imaging for determining treatment response in soft-tissue sarcomas.
PURPOSE: To determine the added value of quantitative diffusion-weighted and dynamic contrast material-enhanced imaging to conventional magnetic resonance (MR) imaging for assessment of the response of soft-tissue sarcomas to neoadjuvant therapy. MATERIALS AND METHODS: MR imaging examinations in 23 patients with soft-tissue sarcomas who had undergone neoadjuvant therapy were reviewed by two readers during three sessions: conventional imaging (T1-weighted, fluid-sensitive, static postcontrast T1-weighted), conventional with diffusion-weighted imaging, and conventional with diffusion-weighted and dynamic contrast-enhanced imaging. For each session, readers recorded imaging features and determined treatment response. Interobserver agreement was assessed and receiver operating characteristic analysis was performed to evaluate the accuracy of each session for determining response by using results of the histologic analysis as the reference standard. Good response was defined as less than or equal to 5% residual viable tumor. RESULTS: Of the 23 sarcomas, four (17.4%) showed good histologic response (three of four with >95% granulation tissue and <5% necrosis, one of four with 95% necrosis and <5% viable tumor) and 19 (82.6%) showed poor response (viable tumor range, 10%-100%). Interobserver agreement was substantial or excellent for imaging features in all sequences (k = 0.789-1.000). Receiver operating characteristic analysis showed an increase in diagnostic performance with the addition of diffusion-weighted and dynamic contrast-enhanced MR imaging for prediction of response compared with that for conventional imaging alone (areas under the curve, 0.500, 0.676, 0.821 [reader 1] and 0.506, 0.704, 0.833 [reader 2], respectively). CONCLUSION: Adding functional sequences to the conventional MR imaging protocol increases the sensitivity of MR imaging for determining treatment response in soft-tissue sarcomas.
Authors: Harriet C Thoeny; Frederik De Keyzer; Vincent Vandecaveye; Feng Chen; Xihe Sun; Hilde Bosmans; Robert Hermans; Eric K Verbeken; Chris Boesch; Guy Marchal; Willy Landuyt; Yicheng Ni Journal: Radiology Date: 2005-09-28 Impact factor: 11.105
Authors: A Preda; P A Wielopolski; T L M Ten Hagen; M van Vliet; J F Veenland; G Ambagtsheer; S T van Tiel; M W Vogel; A M M Eggermont; G P Krestin; C F van Dijke Journal: MAGMA Date: 2004-10-10 Impact factor: 2.310
Authors: Wayne L Monsky; Bedro Jin; Chris Molloy; Robert J Canter; Chin Shang Li; Tzu C Lin; Daniel Borys; Walter Mack; Isaac Kim; Michael H Buonocore; Abhijit J Chaudhari Journal: Anticancer Res Date: 2012-11 Impact factor: 2.480
Authors: Janelle M Meyer; Kelly S Perlewitz; James B Hayden; Yee-Cheen Doung; Arthur Y Hung; John T Vetto; Rodney F Pommier; Atiya Mansoor; Brooke R Beckett; Alina Tudorica; Motomi Mori; Megan L Holtorf; Aneela Afzal; William J Woodward; Eve T Rodler; Robin L Jones; Wei Huang; Christopher W Ryan Journal: Clin Cancer Res Date: 2013-10-16 Impact factor: 12.531
Authors: Ashok J Theruvath; Florian Siedek; Anne M Muehe; Jordi Garcia-Diaz; Julian Kirchner; Ole Martin; Michael P Link; Sheri Spunt; Allison Pribnow; Jarrett Rosenberg; Ken Herrmann; Sergios Gatidis; Jürgen F Schäfer; Michael Moseley; Lale Umutlu; Heike E Daldrup-Link Journal: Radiology Date: 2020-05-05 Impact factor: 11.105
Authors: Wei Huang; Brooke R Beckett; Alina Tudorica; Janelle M Meyer; Aneela Afzal; Yiyi Chen; Atiya Mansoor; James B Hayden; Yee-Cheen Doung; Arthur Y Hung; Megan L Holtorf; Torrie J Aston; Christopher W Ryan Journal: Tomography Date: 2016-12